Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19250015 | 0.93 | P2RY12 (0.41) | P2RY12ADORA1PRMT6DNPH1 | |
| SCHEMBL18927171 | 0.92 | P2RY12 (0.39) | P2RY12ADORA1PRMT6DNPH1 | |
| SCHEMBL18917301 | 0.92 | P2RY12 (0.39) | P2RY12ADORA1PRMT6DNPH1 | |
| SCHEMBL29749022 | 0.90 | P2RY12 (0.39) | P2RY12ADORA1PRMT6DNPH1 | |
| SCHEMBL31430113 | 0.89 | P2RY12 (0.41) | P2RY12PRMT6DNPH1 | |
| SCHEMBL19250016 | 0.89 | P2RY12 (0.44) | P2RY12DNPH1 | |
| SCHEMBL20022045 | 0.88 | P2RY12 (0.37) | P2RY12ADORA1PRMT6DNPH1 | |
| SCHEMBL17860495 | 0.87 | P2RY12 (0.38) | P2RY12ADORA1PRMT6DNPH1 | |
| SCHEMBL31430083 | 0.87 | P2RY12 (0.39) | P2RY12PRMT6DNPH1 | |
| SCHEMBL22220010 | 0.86 | P2RY12 (0.42) | P2RY12ADORA1PRMT6DNPH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054460-A1 | PHOSPHODIESTERASE-STABLE ENDO-PHOSPHOROTHIOATE- SUBSTITUTED 2'3'-CGAMP ANALOGUES AS AGONISTS OF STIMULATOR OF INTERFERON GENE | PURDUE RESEARCH FOUNDATION (US) | 2025-03-13 | — | — | WO | disclosed |